Published in J Exp Med on June 07, 1999
ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med (2008) 3.39
Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol (2009) 2.43
B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol (2007) 2.08
T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity (2008) 2.03
Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol (2007) 2.00
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol (2007) 1.69
Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J Immunol (2007) 1.36
Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J Exp Med (2010) 1.29
Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J Exp Med (2002) 1.28
Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc Natl Acad Sci U S A (2002) 1.21
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med (2006) 1.17
Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology (2008) 1.10
Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci U S A (2005) 1.08
TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. J Immunol (2013) 1.07
Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum (2011) 1.02
A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation. Autoimmunity (2010) 1.01
Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS One (2009) 0.98
Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice. J Exp Med (2012) 0.96
Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. J Immunol (2010) 0.95
Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance. J Clin Invest (2003) 0.92
Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood (2006) 0.90
A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway. J Exp Med (2003) 0.90
Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl. J Exp Med (2004) 0.88
Contributions of B cells to lupus pathogenesis. Mol Immunol (2013) 0.87
Spontaneous autoimmunity in mice that carry an IghV partial transgene: a required arginine in VHCDR3. Lupus (2009) 0.85
Somatic mutagenesis in autoimmunity. Autoimmunity (2013) 0.84
Spontaneous loss of tolerance of autoreactive B cells in Act1-deficient rheumatoid factor transgenic mice. J Immunol (2013) 0.84
Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity. J Autoimmun (2008) 0.83
New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 0.81
The regulation of autoreactive B cells during innate immune responses. Immunol Res (2008) 0.80
C1q deficiency promotes the production of transgenic-derived IgM and IgG3 autoantibodies in anti-DNA knock-in transgenic mice. Mol Immunol (2007) 0.78
Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE. J Autoimmun (2015) 0.77
A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice. J Immunol (2013) 0.76
IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity. Clin Med Insights Pathol (2016) 0.75
Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice. J Immunol (2016) 0.75
Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction. Nat Commun (2016) 0.75
Specific recognition of a dsDNA sequence motif by an immunoglobulin VH homodimer. Protein Sci (2004) 0.75
Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity. J Immunol (2017) 0.75
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (1992) 12.92
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87
Murine models of systemic lupus erythematosus. Adv Immunol (1985) 9.79
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature (1983) 8.20
Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol (1989) 8.02
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (1989) 5.48
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38
In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med (1991) 4.98
Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med (1990) 4.46
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature (1994) 4.36
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (1991) 3.32
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J Immunol (1993) 2.86
Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity (1995) 2.55
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (1995) 2.45
The phenotype and fate of the antibody-forming cells of the splenic foci. Eur J Immunol (1996) 2.42
Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self. J Exp Med (1975) 2.40
CD22 is a negative regulator of B-cell receptor signalling. Curr Biol (1997) 2.37
Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med (1992) 2.27
Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med (1986) 2.25
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol (1998) 2.14
Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell (1996) 2.09
The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity (1997) 2.00
Ig H and L chain contributions to autoimmune specificities. J Immunol (1991) 1.96
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol (1998) 1.95
Receptor-mediated inactivation of early B lymphocytes. Nature (1975) 1.90
Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity (1998) 1.88
The site and stage of anti-DNA B-cell deletion. Nature (1995) 1.87
Treatment of murine lupus with monoclonal anti-T cell antibody. J Immunol (1985) 1.87
Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol (1997) 1.85
BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro. Immunity (1997) 1.76
An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J Exp Med (1991) 1.75
Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2- T cells of lpr mice. J Exp Med (1988) 1.69
Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest (1998) 1.65
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol (1986) 1.63
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 1.61
The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med (1993) 1.58
Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol (1992) 1.44
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.41
Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J Immunol (1997) 1.39
Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J Immunol (1992) 1.34
Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J (1995) 1.33
A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol (1990) 1.32
Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J Immunol (1991) 1.32
A role for Fas in negative selection of thymocytes in vivo. J Exp Med (1998) 1.30
Newly produced virgin B cells migrate to secondary lymphoid organs but their capacity to enter follicles is restricted. Eur J Immunol (1987) 1.30
Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J Immunol (1994) 1.30
Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J Exp Med (1995) 1.25
Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J Immunol (1990) 1.20
Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J Exp Med (1995) 1.18
Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity (1998) 1.18
Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J Immunol (1996) 1.16
Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. Int Immunol (1993) 1.14
Ipr gene control of the anti-DNA antibody response. J Immunol (1982) 1.13
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
T helper cells in murine germinal centers are antigen-specific emigrants that downregulate Thy-1. J Exp Med (1996) 1.13
Fluorescent tandem phycobiliprotein conjugates. Emission wavelength shifting by energy transfer. Biophys J (1983) 1.12
Lack of allelic exclusion permits autoreactive B cells to escape deletion. J Immunol (1994) 1.12
Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity (1995) 1.10
Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int Immunol (1990) 1.10
Successive changes of the cellular composition in lymphoid organs of MRL-Mp/lpr-lpr mice during the development of lymphoproliferative disease as investigated in cryosections. Clin Immunol Immunopathol (1988) 1.04
Characterization of anti-single-stranded DNA B cells in a non-autoimmune background. J Immunol (1997) 1.03
Persistence of functionally compromised anti-double-stranded DNA B cells in the periphery of non-autoimmune mice. Int Immunol (1997) 1.01
B cells are anergic in transgenic mice that express IgM anti-DNA antibodies. Eur J Immunol (1993) 0.97
Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J Immunol (1994) 0.94
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1995) 0.94
T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE). Clin Exp Immunol (1992) 0.94
Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice. Clin Immunol Immunopathol (1998) 0.92
lpr T cells are necessary for autoantibody production in lpr mice. J Immunol (1993) 0.91
Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells. J Immunol (1999) 0.88
Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J Immunol (1998) 0.88
Immature B lymphocytes are deficient in expression of the src-family kinases p59fyn and p55fgr1. J Immunol (1995) 0.87
Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice. Immunol Rev (1997) 0.86
Cellular events during the primary immune response in the spleen. A fluorescence- light- and electronmicroscopic study in germfree mice. Cell Tissue Res (1977) 0.86
Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin Immunol Immunopathol (1996) 0.85
Tetraparental mice reveal complex cellular interactions of the mutant, autoimmunity-inducing lpr gene. J Immunol (1992) 0.81
Marked depletion at the late pro-B cell stage in the bone marrow of lpr mice correlates with the development of lymphadenopathy but not autoimmunity. Eur J Immunol (1996) 0.76
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1982) 11.15
Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc Natl Acad Sci U S A (1983) 3.90
Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science (1983) 3.82
Translocation of an immunoglobulin kappa locus to a region 3' of an unrearranged c-myc oncogene enhances c-myc transcription. Proc Natl Acad Sci U S A (1983) 3.75
Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science (1984) 3.64
Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt. Proc Natl Acad Sci U S A (1983) 3.53
Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma. Proc Natl Acad Sci U S A (1983) 3.46
Assignment of the genes for human lambda immunoglobulin chains to chromosome 22. Nature (1981) 3.43
Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc Natl Acad Sci U S A (1983) 3.43
Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science (1983) 3.40
Translocation of immunoglobulin VH genes in Burkitt lymphoma. Proc Natl Acad Sci U S A (1982) 3.30
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res (1996) 2.53
Residues that mediate DNA binding of autoimmune antibodies. J Immunol (1993) 2.37
Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. Science (1985) 2.33
Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol (2011) 2.26
cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc Natl Acad Sci U S A (1990) 2.01
Ig H and L chain contributions to autoimmune specificities. J Immunol (1991) 1.96
Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region. Mol Cell Biol (1985) 1.90
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A (1984) 1.79
Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science (1986) 1.75
Locus of the alpha-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias. Science (1985) 1.71
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
Deletion and editing of B cells that express antibodies to DNA. J Immunol (1994) 1.62
Gene for the human T cell differentiation antigen Leu-2/T8 is closely linked to the kappa light chain locus on chromosome 2. J Exp Med (1985) 1.59
Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells. Proc Natl Acad Sci U S A (1983) 1.48
Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids. Science (1984) 1.46
Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia. Proc Natl Acad Sci U S A (1986) 1.41
Light chain contribution to specificity in anti-DNA antibodies. J Immunol (1995) 1.39
Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harb Symp Quant Biol (1989) 1.35
Chromosome localization of the gene for human terminal deoxynucleotidyltransferase to region 10q23-q25. Proc Natl Acad Sci U S A (1985) 1.35
MYC oncogene involved in a t(8;22) chromosome translocation is not altered in its putative regulatory regions. Proc Natl Acad Sci U S A (1987) 1.27
The C-terminal tail of UNC-60B (actin depolymerizing factor/cofilin) is critical for maintaining its stable association with F-actin and is implicated in the second actin-binding site. J Biol Chem (2000) 1.24
Location of gene for beta subunit of human T-cell receptor at band 7q35, a region prone to rearrangements in T cells. Science (1985) 1.20
The translocated c-myc oncogene of Raji Burkitt lymphoma cells is not expressed in human lymphoblastoid cells. Proc Natl Acad Sci U S A (1985) 1.19
Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J Exp Med (1995) 1.18
The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci U S A (1984) 1.17
Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. Proc Natl Acad Sci U S A (1984) 1.16
Laparoscopy not recommended for routine appendectomy in men: results of a prospective randomized study. Surgery (1996) 1.11
Molecular genetics of human B- and T-cell neoplasia. Cold Spring Harb Symp Quant Biol (1986) 1.11
Secretion of human immunoglobulins by mouse myeloma x Daudi somatic cell hybrids. Eur J Immunol (1982) 1.10
Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity (1995) 1.10
Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma. Science (1983) 1.10
Lineage infidelity of a human myelogenous leukemia cell line. Blood (1984) 1.07
New Colorimetric reaction for end-point, continuous-flow, and kinetic measurement of urea. Clin Chem (1975) 1.05
Immune responses to nucleic acid vaccines to rabies virus. Virology (1995) 1.05
Purification, cDNA cloning and expression of an insect defensin from the great wax moth, Galleria mellonella. Insect Mol Biol (2004) 1.05
Characterization of anti-single-stranded DNA B cells in a non-autoimmune background. J Immunol (1997) 1.03
Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int Immunol (1999) 1.03
Persistence of functionally compromised anti-double-stranded DNA B cells in the periphery of non-autoimmune mice. Int Immunol (1997) 1.01
B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice. J Immunol (1995) 0.99
Phosphorylation of the RNA polymerase II largest subunit during heat shock and inhibition of transcription in HeLa cells. J Cell Physiol (1994) 0.98
Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol (2001) 0.98
Molecular characterization of the VLDL receptor homolog mediating binding of lipophorin in oocyte of the mosquito Aedes aegypti. Insect Biochem Mol Biol (2001) 0.97
Galactose-carrying polymers as extracellular matrices for liver tissue engineering. Biomaterials (2005) 0.96
Alterations in splenic architecture and the localization of anti-double-stranded DNA B cells in aged mice. Int Immunol (2000) 0.94
The c-myc oncogene is translocated to the involved chromosome 12 in mouse plasmacytoma. Proc Natl Acad Sci U S A (1985) 0.94
The human Vpre B gene is located on chromosome 22 near a cluster of V lambda gene segments. Immunogenetics (1988) 0.92
Breast cancer activists seek voice in research decisions. Science (1995) 0.92
Ingestion of Rhus chicken causing systemic contact dermatitis in a Korean patient. Clin Exp Dermatol (2010) 0.92
Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Immunol (2000) 0.91
Coexpression of translocated and normal c-myc oncogenes in hybrids between Daudi and lymphoblastoid cells. Science (1985) 0.90
Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. J Clin Endocrinol Metab (2010) 0.89
Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle. J Immunol (2001) 0.89
Disease specific intelligent pre-fetch and hanging protocol for diagnostic neuroradiology workstations. Proc AMIA Symp (2001) 0.89
Fas receptor expression on B-lineage cells. Eur J Immunol (1995) 0.88
A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Clin Exp Dermatol (2011) 0.87
Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia. Blood (1992) 0.87
Chromosome translocations and B cell neoplasia. Lab Invest (1984) 0.87
Phosphorylation state of the RNA polymerase II C-terminal domain (CTD) in heat-shocked cells. Possible involvement of the stress-activated mitogen-activated protein (MAP) kinases. Eur J Biochem (1995) 0.86
Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice. J Immunol (2001) 0.85
The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int Immunol (2000) 0.84
Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Clin Immunol (1999) 0.83
Transition from pemphigus vulgaris to pemphigus foliaceus. Br J Dermatol (1997) 0.83
Hormonal regulation and cellular localization of fatty acid synthase in human fetal lung. Am J Physiol (1999) 0.83
Baculovirus expression vectors that incorporate the foreign protein into viral occlusion bodies. Biotechniques (2003) 0.82
Modulation of MnSOD protein in response to different experimental stimulation in Hyphantria cunea. Comp Biochem Physiol B Biochem Mol Biol (2010) 0.82
Extramammary Paget's disease of the penis with features of Bowen's disease. Clin Exp Dermatol (2009) 0.82
The locus for the serum prealbumin is proximal to the heavy chain locus on mouse chromosome 12q+. J Immunol (1986) 0.82
[Intestinal parasitic diseases in an urban environment in Sahel. A study in a district of Niamey, Niger]. Bull Soc Pathol Exot (1998) 0.81
Scar sarcoidosis on a hypertrophic scar. Clin Exp Dermatol (2014) 0.81
Self-reactive B cells in nonautoimmune and autoimmune mice. Immunol Res (1998) 0.81
Effects of altered Bcl-2 expression on B lymphocyte selection. Ann N Y Acad Sci (1997) 0.80
Comparative analysis of two attacin genes from Hyphantria cunea. Comp Biochem Physiol B Biochem Mol Biol (2008) 0.80
Role of E-cadherin molecules in spheroid formation of hepatocytes adhered on galactose-carrying polymer as an artificial asialoglycoprotein model. Biotechnol Lett (2005) 0.79
Immunolocalization of basic fibroblast growth factor in porcine epiphyseal growth plate. Domest Anim Endocrinol (1997) 0.79
Response of murine gamma delta T cells to the synthetic polypeptide poly-Glu50Tyr50. J Immunol (2000) 0.79
Down-regulation of PPARgamma2-induced adipogenesis by PEGylated conjugated linoleic acid as the pro-drug: Attenuation of lipid accumulation and reduction of apoptosis. Arch Biochem Biophys (2006) 0.79
Unusual presentation of onychomycosis caused by Exophiala (Wangiella) dermatitidis. Clin Exp Dermatol (2010) 0.79
The induction of immediate early genes in postischemic and transplanted livers in rats. Its relation to organ survival. Transplantation (1994) 0.78
Analytical modeling and numerical simulation of forces in an endoluminal graft. J Endovasc Ther (2001) 0.78